Ji-xian Huang

Therapeutic immune monitoring of CD4+CD25+ T cells in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors

Xuan Zhou, Xiaoli Liu, N. Xu, 2017, Oncology letters.

Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia

Xuan Zhou, Xiao-li Liu, Z. Fan, 2016, Journal of Hematology & Oncology.

Inhibition of Siah2 Ubiquitin Ligase by Vitamin K3 Attenuates Chronic Myeloid Leukemia Chemo-Resistance in Hypoxic Microenvironment

Xuan Zhou, Ya-juan Xiao, Xiaoli Liu, 2018, Medical science monitor : international medical journal of experimental and clinical research.

[Clinical characteristics of chronic myeloid leukemia with T315I mutation and the efficacy of ponatinib].

Xuan Zhou, Xuejie Jiang, C. Yin, 2019, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

CDKN2 Gene Deletion as Poor Prognosis Predictor Involved in the Progression of Adult B-Lineage Acute Lymphoblastic Leukemia Patients

Na Xu, Jing Sun, Xuan Zhou, 2015, Journal of Cancer.

Integrative Genomic Analysis Reveals Cancer-Associated Gene Mutations in Chronic Myeloid Leukemia Patients with Resistance or Intolerance to Tyrosine Kinase Inhibitor

Xuan Zhou, C. Yin, J. Qin, 2020, OncoTargets and therapy.

Prognostic Significance of Monosomal Karyotype in Adult Patients With Acute Myeloid Leukemia Treated With Risk-Adapted Protocols.

Xuan Zhou, Xiao-li Liu, N. Xu, 2015, Clinical lymphoma, myeloma & leukemia.

De‐escalation or discontinuation of tyrosine kinase inhibitor in patients with chronic myeloid leukemia: A multicentral, open‐label, prospective trial in China

Li-ping Ma, Xuan Zhou, C. Yin, 2022, EJHaem.